Diabetic Management Using New Medications, and the Cost Barriers

Upon completion of this activity, the Learner will be able to do the following regarding Type 2 Diabetes Mellitus.

Learning Objectives:

  1. Identify barriers to effective diabetic treatment.
  2. Develop strategies to optimize patient-centered diabetic care.
  3. Determine Pharmaceutical company assistance and other resources available.
  4. Develop a resource base to decrease confusion and increase options for diabetic care.

This program was planned and implemented by the Kansas City University of Medicine and Biosciences and was accredited by the Missouri Association of Osteopathic Physicians & Surgeons (MAOPS).

The Missouri Association of Osteopathic Physicians and Surgeons is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians and designates this program for a maximum of 1.0 AOA Category 1-A credits and will report CME and specialty credits commensurate with the extent of the physician's participation in this activity.

The Missouri Association of Osteopathic Physicians and Surgeons designates this live activity for a maximum of one AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Grievance Policy:
All grievances should be in writing and should specify the nature of the grievance.  Initially, all grievances should be directed to MAOPS Executive Director, who will then forward said grievance to the Education & Convention Committee.  All grievances will receive an initial response in writing within 30 days of receipt.  If the participant does not receive a satisfactory response, then they can then submit a complaint in writing to the Council on Continuing Medical Education of the AOA at 142 East Ontario Street, Chicago, IL 60611.